There are 700 resources available
356P - Late-onset pancreatic cancer (LOPC) patients (pts) treated at an Italian center: A real-word analysis from the Gemelli GENERATOR experience
Presenter: Antonia Cosmai
Session: Poster Display session
357P - Single center analysis of DNA damage repair (DDR) germline mutations (GM) in patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC).
Presenter: Giovanni Trovato
Session: Poster Display session
358P - Clinical outcomes of patients with chemo-refractory pancreatic adenocarcinoma participating in phase I clinical trials
Presenter: Mitsuhito Sasaki
Session: Poster Display session
360P - Prognostic nutritional index and systemic immune-inflammation index as biomarkers in metastatic pancreatic cancer
Presenter: Julia Homolova
Session: Poster Display session
361P - Modified FOLFIRINOX as second-line therapy in 140 patients with pancreatic adenocarcinoma patients who have failed first-line treatment using gemcitabine and nab-paclitaxel
Presenter: Dermot Farrell
Session: Poster Display session
362P - Impact of an interprofessional clinic on pancreatic cancer outcomes
Presenter: Gordon Moffat
Session: Poster Display session
365P - Pancreatic cancer in young patients under the age of 45 years old: A comparative study with older patients
Presenter: Ghzel Sirine
Session: Poster Display session
366P - Survival and local control in patients submitted to locoregional SBRT in pancreatic adenocarcinoma: Real-world outcomes in Brazil
Presenter: Carolina Ferreira
Session: Poster Display session
367P - Chemotherapy sensitivity in pancreatic neoplasms with PALB2 Gene mutations: First results of PALB2 pancreatic cancer study
Presenter: Paula Cerda Serda
Session: Poster Display session
368P - The role of pretreatment serum interleukin 6 in predicting short-term mortality in patients with advanced pancreatic cancer
Presenter: Dongwoo Cho
Session: Poster Display session